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Abstract
Infections due to Hepatitis B and Hepatitis C viruses are significant health problems around the globe, Nigeria inclusive. Asymptomatic Hepatitis B and C infections 
are common and when occurring in pregnancy can be transmitted to the new born. To determine the prevalence rate of asymptomatic hepatitis B and C infections 
among pregnant women, 406 pregnant women attending antenatal clinic at University Health centre and Our Lady of Apostle hospital, all in Jos, Plateau State were 
recruited for the study. The study was also carried out to determine whether liver aminotransferases and serum albumin can be affected by hepatitis infection during 
pregnancy. Demographic and past clinical histories were obtained using a questionnaire. Serum samples from each study subject were tested using third-generation 
enzyme immunoassay kits for hepatitis B surface antigen (HBsAg) and antibodies against hepatitis C (HCV). Serum Alanine Aminotransferase (ALT) and serum 
aspartate aminotransferase (AST) activities were also estimated in all subjects using Reitman-Frankel method. Also serum albumin was measured in all subjects 
using Bromocresol green (BCG) method by Teitz. The results showed that 10.0% and 1.2% of the 406 blood samples tested positive on HBV and HCV, respectively. 
Furthermore, 1.2% of the 406 blood samples tested positive with both HBV and HCV. The mean AST levels for HBsAg negative and positive subjects were 10.55 
± 0.05 and 12.16 ± 0.29, respectively while the mean ALT levels were 5.54 ± 0.005 and 8.01 ± 0.01, respectively. The mean AST for anti-HCV negative and positive 
subject were 10.67 ± 0.01 and 9.01 ± 0.05, respectively while ALT were 5.71 ± 0.01 and 4.01 ± 0.05, respectively. There was a significant increase in levels of AST and 
ALT between the HBsAg positive and negative pregnant subjects (P < 0.05). Furthermore, the mean serum albumin level for HBsAg positive and negative pregnant 
subjects were 30.60 ± 2.75 and 35.58 ± 3.82, respectively. Also, the mean albumin level for HCV positive and negative pregnant subjects were 28.5 ± 2.12 and 35.55 
± 3.7, respectively. There was a significant increase in albumin level between HBsAg and HCV positive and negative pregnant subjects (P < 0.05). HBV and HCV 
infection can be present in pregnant women and can alter liver aminotransferases and serum albumin. Routine screening of pregnant women for HBV and HCV 
should be instituted in order to detect infection early and prevent or reduce vertical or prenatal transmission.
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Introduction
Viral hepatitis is the inflammation of the liver caused by infection 
with hepatitis viruses. Infection with hepatitis B virus or hepatitis C 
virus are public health problems and are highly endemic in Sub-
Saharan Africa [1,2]. Worldwide, there are about 350 million HBV 
carriers [3]. HBV and HCV infections are major causes of morbidity 
and mortality.
Hepatits B virus is a DNA virus of the family hepadneviridae and 
the causative agent of hepatitis B infection [4]. It is 50-100 times more 
infectious than HIV and 10 times more infectious than hepatitis C. 
Many carriers do not realize they are infected with the virus, thus it is 
referred to as a ‘silent killer’ [5].
Hepatitis C virus (HCV) is an RNA virus of the flaviviridae family 
and appears to have humans and chimpazees as the species susceptible 
to its infection [6]. About 170 million people are infected with HCV 
worldwide [7].
Both viruses are transmitted through contact with infected blood, 
sexual intercourse and vertical transmission (mother-to-child) [8]. 
Maternal mortality has been shown to increase in pregnant women 
with liver cirrhosis.
HBV and HCV account for a substantial portion of liver diseases 
worldwide and infected individuals can remain asymptomatic for 
decades. However, more than 80% of them become chronic carriers 
which result in an increased risk of liver cirrhosis, liver cancer and liver 
failure 20-30 years later. They share similar modes of transmission. Co-
infection is not uncommon especially in areas of high prevalence and 
among people at high risk for parental infection.
In Nigeria, the prevalence rate of HBV and HCV in pregnant 
women differ from one locality to another. Yakasai et, al. [9] reported a 
prevalence of 7.9% HBsAg in pregnant women in Kano, Nigeria. While 
Oladeinde et, al. [10] reported a prevalent rate of 8 (2.2%) and 3 (0.8%) 
of HBV and HCV infections, respectively among pregnant women in 
Benin city, Nigeria. Co-infection of HBV and HCV seems to result in 
more severe disease than either infection alone.
Globally hepatitis B virus (HBV) infection is the most common 
form of chronic hepatitis around the world. Chronic carriers can 
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continue to transmit the disease for many years, before becoming 
symptomatic [11]. Together hepatitis B and C represent one of the 
major threats to global health. Infection occurs very often in early 
childhood when it is asymptomatic and then lead to the chronic carrier 
state; chronic HBV infection leads to increase risk for chronic hepatic 
insufficiency, cirrhosis, and hepatocellular carcinoma (HCC) [11].
In many developed countries (e.g. those in Western Europe and 
North America) patterns of transmission are different from those 
in developing countries. The majority of infections in developing 
countries are transmitted by sexual activity and drug use especially 
among young adults [12].
Hepatitis B is a major infectious occupational hazard of health 
worker. Hepatitis B Virus is not spread by contaminated food or 
water and cannot be spread casually in the work place. Hepatitis B is 
transmitted through contact with an infected person’s blood, semen or 
other body fluid. 
Materials and methods
Study area 
This study was carried out in the University Health Centre (UHC) 
and Our Lady of Apostle (OLA) hospital, both located in Jos North 
Local government of Plateau State. 
University Health Centre is located in the permanent site of 
University of Jos, and is positioned to take care of the health needs 
of students, staff and their dependents. Anti-natal care is also given to 
both staff and students. OLA hospital is located in the heart of the city 
of Jos being a popular maternity place for different ethnic and religious 
groups, both urban and rural women use OLA hospital for their ante-
natal care center. the study was conducted on 406 pregnant women 
attending ante-natal clinic in UHC and OLA hospital
Ethical clearance
Ethical clearance were sought and obtained from UHC and OLA 
hospital management before commencing the study. The nature of 
the study was explained to the patients in a simple language to their 
understanding and their consent was obtained before enrolment into 
the study
A well designed personal data information sheet was used to 
gather information regarding age, surgery, HBsAg vaccination, blood 
transfusion. Blood sample was obtained by venipuncture. Ten millitre 
of blood sample was collected from a prominent vein on the arm of each 
of the women into z10 tube. It was allowed to clot and then centrifuged 
at 1000rpm for 5 minutes and serum separated and stored at - 20oC.
The samples were evaluated for the presence of HBV surface 
antigen and anti-HCV using a rapid lateral chromatographic 
immunoassay kit (WHOBC-ACON, Biotech, Hangzhou, China) 
and a rapid visual immunoassay kit (WHOBC – Lebman, Hamburg, 
Germany). Assays were done at room temperature; the pouch was opened 
under room temperature because the test strips need to equilibrate with 
the room temperature prior to testing. The serum was also brought out of 
refrigerator, for it also to equilibrate with room temperature before testing. 
Test procedure
With the arrows pointing downwards, it was immersed into the 
serum for 10-15 seconds. The maximum line (max) on the strip was 
observed in order to avoid exceeding the line. The strip was then placed 
on a non-absorbent surface. The timer was then set for fifteen (15) 
minutes, awaiting the red line to appear or not. Two distinct red lines, 
one on the control region (C) while the other on the test (T) region.
Interpretation of result
Negative: Only one color band appears on the control region. 
No apparent band on the test region. This indicates that there is no 
detectable anti – HCV in the whole blood. 
Positive: Distinct color bands appears on the control and test 
region. Both test line and control line indicate that the specimen 
contains detectable amount of anti-HCV. 
Invalid: No visible band at all or only one colored band appears on 
the test region, this is an indication of a possible error in performing 
the test. 
Liver function test
Liver Function tests (LFTs) are groups of clinical biochemistry 
laboratory assays designed to give information about the state of a 
patients Liver.
The parameters measured include Prothrombin time (PT), 
albumin, bilirubin (direct and indirect). Liver transaminases AST/
ALT. These are called Liver damage test-biomarker of Liver injury in 
a patient with some degree of intact liver function. For the purpose 
of this research, albumin, Aspartate transaminase (AST), Alanine 
transaminase (ALT) were determined on the pregnant women who are 
positive to HBV and HCV infection. 
Albumin test
Albumin is a protein made specifically by the liver. It is the main 
constituent of total protein (the remaining from globulins). Albumin 
levels are decreased in chronic liver disease such as cirrhosis (Medline 
plus Encyclopedia). 
Principle: The measurement of Serum albumin is based on its 
quantitative binding to the indicator 3,3:5.5 – tetrabromom-cresol 
sulphonephthalein (bromocresol green, BCG). The albumin – BCG – 
complex absorbs maximally at 578nm, the absorbance being directly 
proportional to the concentration of albumin in the sample. 
Statistical analysis
The prevalence of each viral infection (HBV and HCV) was 
determined from the proportion of the positive individuals in the total 
population under consideration and expressed as a percentage. The chi-
square test was employed to determine the relationships between age and 
presence of risk factors with HBV and HCV infection at P < 0.05.
Also t-test for AST, ALT and albumin level among the pregnant 
women were tested to determine if their level is significant or not in the 
study at P < 0.05. 
The results of the prevalence study are presented in the Table 1. It 
shows that out of 406 pregnant women tested, 41(10%) were positive 
for HBsAg and 5 (1.2%) were positive for anti-HCV giving an overall 
prevalence of 10% and 1.2%, respectively. Also the study shows that 
out of 406 pregnant women tested, 5 (1.2%) were positive for HBV and 
HCV infection showing a prevalence of 1.2% of co-infection with HBV 
and HCV. The study shows that the prevalence of HBsAg and HCV is 
significant at P < 0.05. 
Table 2 shows prevalence of HBsAg and anti-HCV among the 
pregnant women based on age group. The prevalence of HBsAg was 
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highest among the age group (15-24years) while Anti-HCV was seen 
in age group 25-34years. The prevalence in age group 15-24 year was 
significant at (P < 0.05) while the prevalence rate in age group of 25-34 
year and 35-44 year were not significant when compared at (P < 0.05).
Table 3 shows the percentage of those with history of blood 
transfusion that were positive for HBsAg and anti HCV as 4.2% and 
0.8% respectively, and those with no history of blood transfusion 
that were positive for HBsAg and anti HCV as 33.3% and 3.3% 
respectively. There was no significant difference when those who had 
blood transfusion and those who did not were compared. Also there 
was no significance difference in HCV individuals. The percentage of 
those with history of surgery that were positive for both HBςAg and 
anti HCV as 33.3% and 3.3% respectively. There was no significant 
difference when those who had blood transfusion and those who did 
not were compared. Also, there was no significance difference in HCV 
individuals. The percentage of those with history of surgery that were 
positive for both HBsAg and Anti HCV were 6.9% and 0%, respectively 
and those with no history of surgery who were positive for HBsAg 
and anti HCV were 14.2% and 0%, respectively. However, there was 
no significant difference between them. Furthermore, the percentage 
of those with family history of hepatitis who were positive for HBsAg 
and anti HCV were 9.5% and 1%, respectively and those who were not 
positive for HBsAg and Anti HCV were10.9% and 1.8%, respectively. 
There was also no significant difference when compared. 
Table 4 shows the mean AST levels for HBsAg negative and 
positive subjects were 10.55 ± 0.05 and 12.16 ± 0.29, respectively while 
the mean ALT levels were 5.54 ± 0.005 and 8.01 ± 0.01, respectively. 
There was a significant difference in mean AST level between those 
who were HBsAg positive and those that were negative. Also there 
was a significant difference in their mean ALT levels (P < 0.05) when 
compared. The mean AST level for anti-HCV negative and positive 
subjects were 10.01 ± 0.09 and 10.67 ± 0.01 respectively while their 
mean ALT were 9.01 ± 0.05 and 5.21 ± 0.01. There was a significant 
difference in mean AST and ALT levels between those who were HCV 
positive and those who were negative when compared. 
Table 5 shows that the mean albumin level for HBsAg negative and 
positive subjects were 35.58 ± 3.82 and 30.60 ± 2.75, respectively. There 
was a significant difference when compared. Also the mean albumin 
level for anti HCV negative and positive subjects were 35.55 ± 3.7 and 28.5 
± 2.12. There was a significant difference when compared at P < 0.05.
Discussion 
The prevalence of hepatitis B and C infection varies in different 
parts of the world from country to country, and from one region to 
another region and from one population group to another in a country 
[13] and since pregnant women have depressed immunity, infections 
of HBV and HCV are of clinical importance. 
The study shows that the prevalence (10.0%) of HBV in the 
pregnant women is within the intermediate endemicity according to 
WHO criteria [14]. Uneke et, al. [15] classified high endemicity from 
HBV infection and defined it as HBsAg greater than 7% in an adult 
population. This also supports the WHO (1990) report for Nigeria as 
highly endemic area with prevalence greater than 8%. The prevalence 
of HBsAg found in pregnant women attending antenatal in Jos falls 
within the range of reports given in other studies carried out in other 
parts of Nigeria, Africa and the rest of the world. In reported studies 
for hepatitis B carried out in some parts of Nigeria, there were higher 
prevalence rates of 12.8% in Minna [16], 15.8% in Maiduguri [17], 
11% in Makurdi [18].  Lower prevalence’s reported include 2.19% in 
Benin City [19], 8.3% in Zaria [20] and 5.7% in Ilorin. In some African 
countries, there were high prevalence rates of 17.3% in Burkina faso. 
Lower reports were 5.3% in Ethiopia, 6.3% in Tanzania. In comparison 
to other findings from the rest of the world were 2.11% in Northern 
Turkey 12% in Taiwan. These variations noticed may be related to the 
peculiarities in the modes of transmission of HBsAg and HCV dictated 
by socio cultural practices and environmental factors.
A prevalence of 1.3% HCV in the studied population was found to 
be low when compared to other studies carried out in Nigeria. Paul et, 
al. reported a 12% in South West Nigeria and 2.5% in Maiduguri [17]. 
This variation noticed may be related to the peculiarities in the modes of 
transmission of HCV dictated by socio-cultural and environmental factors.
My findings compared to findings from other African countries, 




No. Positive Result 
(%)
No. Negative Result 
(%) Χ
2 P-value
HBsAg 41 (10.0) 365 (90) 258.562 0.000
Anti HCV 5 (1.2) 401 (98.7) 389.244 0.000
HBV/anti HCV 5 (1.2) 401 (98.7) 389.244 0.000





No HBsAg positive 
(%)
No of HCV 
positive (%) Χ
2 P-value
15-24 162 24 (15.0) 0 (0.0) 24.00 0.000
25-34 114 11 (9.5) 5 (4.8) 52.25 0.134
35-44 81 6 (6.6) 0 (0.0) 6.000 0.014
45-54 49 0 (0.0) 0 (0.0) 0.000 0.000
Table 2. Prevalence of HBV and Anti HCV among pregnant women based on Age group.




































Table 3. Prevalence of HBV and Anti HCV in relation to some associated risk factors 
among the pregnant women.Significance = P < 0.05, X2 = Chi-square, HBT = History or 
Blood transfusion, HS = History of surgery, FHHI = Family history of hepatitis infection.
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Table 4. T-test for AST and ALT among the pregnant women tested.Significance = P < 0.05, 
S.D. = Standard deviation, AST = Aspartate Transaminase, ALT = Alanine Transaminase.
Group Parameter Status Mean±SD(IU/L) X2 P-value
HBsAg Albumin Positive (n = 41)Negative (n = 365)
30.60±2.75
35.58±3.82 258.562 0.00
HCV Albumin Positive (n = 5)Negative (n = 401)
28.5±2.12
35.55±3.7 386.246 0.000
Table 5. T-test for serum albumin among the pregnant women tested. Significance = P < 
0.05, S.D. = Standard deviation.
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d’Ivoire [22]. My finding was in agreement with the research carried 
out in Sudan. There was a lower prevalence rate of 0.01% in the United 
Kingdom [21]. A prevalence of 1.3% of mix infection for HBV and 
HCV in the tested population was found to be high when compared to 
other studies carried out in other part of Nigeria. Ose et, al. reported 
a 0.57% in south west Nigeria. This could be as a result of lack or poor 
public enlightenment.
This study also showed that out of 406 respondents, the highest 
prevalence for HBsAg were within the age group 15-24 years. In 
this study, pregnancy caused no alteration in the levels of the AST 
aminotransferase. Although the results of the aminotransferases 
assayed were normal in all subjects there was a significant increase 
in ALT and AST levels when HBsAg positive and negative pregnant 
subjects were compared. There was also a high frequency of HBsAg 
seropositivity as compared to HCV among pregnant women in this 
study and an increased serum AST and ALT level in the positive 
subjects than in the negative subjects. This is in line with the work of 
Helsper et, al. [23] who detected increased ALT in association with 
HCV infection in primary care patients.
Furthermore, in this study, serum albumin was normal in both 
HBsAg and HCV negative pregnant women but slightly decreased in 
HBsAg and HCV positive pregnant women. This is in line with other 
studies that discovered that albumin level is normal in chronic hepatitis 
subjects but is usually decreased in acute hepatitis subjects.
The dangers inherent in the observed cases call for conscious 
effort to be addressed especially as it has been reported that infection 
acquired perinatally and in early childhood is usually asymptomatic 
but in the people who experience the disease, the severity of symptoms 
and illness vary widely [24-31].
Conclusion 
The study revealed that HBV and HCV could be present in 
pregnant women and that both infections can co-exist in a pregnant 
woman. Also the study revealed that these viruses can alter liver serum 
albumin and liver enzymes (ALT and AST). There is therefore urgent 
need for free screening of all pregnant mothers for HBV and HCV. In 
addition, there should be robust immunizations of all HBsAg negative 
pregnant women and their infants against HBV. The study also showed 
a high prevalence of HCV in pregnant women studied. 
In conclusion, therefore both HBV and HCV can be present in 
pregnant women and can alter liver amino transferases and serum 
albumin. These liver damage markers were not indicated in the 
pregnant women studied.
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